Canagliflozin/metformin IR FDC tablets

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

Healthy

Phase 1

A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy Volunteers

CompletedNCT01508182

Janssen Research & Development, LLCHealthy

Start: 2012-01-31End: 2012-03-31Updated: 2013-01-16

A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy Volunteers

CompletedNCT01508195

Janssen Research & Development, LLCHealthy

Start: 2012-01-31End: 2012-03-31Updated: 2013-01-31